Overview

162 mg of Aspirin for Prevention of Preeclampsia

Status:
Recruiting
Trial end date:
2022-06-09
Target enrollment:
Participant gender:
Summary
This is a study to assess if 162 mg of aspirin will decrease rates of preeclampsia in pregnant patients compared to 81 mg of aspirin.
Phase:
Phase 4
Details
Lead Sponsor:
Methodist Medical Center of Illinois
Collaborators:
UICOM Peoria Family Medicine Residency
University of Illinois College of Medicine at Peoria
Treatments:
Aspirin